Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Tuesday, July 17, 2018


Epic Update Glenmark
Glenmark Pharmaceuticals has received final approval from the US health regulator for Colesevelam Hydrochloride for oral suspension, used to lower cholesterol levels in the blood. The approval has been granted by the United States Food and Drug Administration (USFDA) in the strengths of 1.875 grams/packet and 3.75 grams/packet, the company said in a BSE filing today.

For more information on commodity tips

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »